Call for Abstracts | The 78th Annual Scientific Meeting of the Japanese Association for Thoracic Surgery

Application Period

Noon, Friday, February 17, 2025

–

Noon, Friday, April 25, 2025
(JST/GMT+9)

Noon, Friday, May 9, 2025
(JST/GMT＋9)

Abstract submission is closed.
Thank you for your submission.

Application Eligibility

Foreign presenters and Co-speakers do not have to be members of the Japanese Association for Thoracic Surgery (JATS).

For those who are interested in becoming JATS members, please contact the Japanese Association for Thoracic Surgery:
1F Teral Koraku Building, 2-3-27 Koraku, Bunkyo-ku, Tokyo 112-0004, JAPAN
Phone: +81-3-3812-4253　Fax: +81-3-3816-4560
URL: http://www.jpats.org/　E-mail: jats-adm@umin.ac.jp

Notes

Presentations must be of original material and being presented for the first time.
Once presentations are approved by the Program Committee, Copyright of the presentations will be assumed by the Japanese Association for Thoracic Surgery.

Submissions

1) Recommended Browsers

To use the online abstract submission system, please use the latest version of Firefox, Google Chrome, Microsoft Edge or Safari.
Internet Explorer (IE) or any other browsers are non-compliant browsers for the online abstract submission system.

2) Abstract Submission Number and Password

During the course of entering your information, you will be required to set your own password.
Upon completion of the abstract submission process, you will be given your abstract submission number. Your abstract submission number and password are very important, so please keep them safe and confidential.
We, the Program Secretariat, will use the abstract submission number when contacting you.
Please note we will not respond to inquiries regarding security issues. Your abstract submission number and password may be used to login and modify your abstract and information up until the submission deadline (noon, April 25, 2025, JST/GMT+9).

3) Abstract Specifications

Language	English
Abstract Title	Limited to 200 characters
Abstract Body	Limited to 2,000 characters
Figures and Tables	A single GIF or JPEG file no larger than 300KB (Portrait or landscape accepted; size will be reduced to approximately 6*4 cm).

4) Confirmation of Submission

After submitting your abstract, you will receive a confirmation e-mail. You may use the submission link to view and modify your abstract at any time up until the abstract submission deadline.

If you do not receive confirmation by e-mail, please contact the Program Secretariat:jats2025-abs@congre.co.jp

5) Notification of Acceptance

The Program committee will carefully review all submitted abstracts, consider the reviews, and then make a final decision on which papers to select.
The first author will receive a notification of acceptance via email by the end of July.
The paper selection results will also be listed on the congress website.
Following the notification of acceptance, the first author must register for the 78th Annual Meeting, and abstracts can only be presented upon receipt of the registration fee.

Call for Primary Sessions

Cardiovascular Surgery

１）Panel Discussion
「Ross procedure: Outcomes and future directions」

Outline: The Ross procedure is gaining attention for younger patients due to benefits like improved survival and no need for anticoagulation. This panel will discuss the latest insights, addressing its indications, challenges like homograft availability, and future directions to optimize its use and outcomes.

２）Symposium
「Reconsoderation of valve sparing root replacement」

Outline: Valve-sparing aortic root replacement has become so widespread that it can be considered a standard procedure, In this session, we will discuss the indications for the procedure, what is necessary for further improvement of the results, and points to keep in mind when performing reoperation.

３）Symposium
「Facts about preemptive TEVAR」

Outline: Preemptive TEVAR is recommended for high-risk cases that are expected to expand in the future, but what is the current situation in Japan as an actual practice? Based on the mid-term results, we will discuss detailed indications, timing of intervention, and treatment methods beyond the guidelines.

Thoracic Surgery

１）Symposium
「Surgeon Training in the era of technical innovation」

Outline: As minimally invasive surgeries such as robotic and uniport approaches have become more widespread and technological innovations such as surgical instruments and devices have continued to advance, the digital transformation (DX), such as preoperative image simulation systems and VR technology, will be expected in surgeon training. Furthermore, from the perspective of medical safety, on-the-job training for young surgeons is limited, and the importance of off-the-job training is increasing. In this session, we would like to discuss the educational policies and training methods of each country and reconsider the education of young surgeons who will lead the next generation.

２）Panel Discussion
「The current position of RATS: Well, what's the robot like?」

Outline: Since RATS was covered by health insurance in 2018, the number of cases has been increasing year by year, and recently, it has been performed at about 5,000 cases per year. In addition to the conventional Davinci (X/Xi), new models have been introduced since 2023, bringing fresh air to the field of thoracic surgery. In this session, we will clarify the features of each model and present their respective range of applications and techniques, aiming to promote the safe and useful dissemination of RATS.

Call for Oral/Mini Oral Sessions

T. Cross-disciplinary

1	T-1	Cross-disciplinary/Combined cardiothoracic surgery (heart/aorta+α)
2	T-2	Cross-disciplinary/Combined cardiothoracic surgery (lung+α)
3	T-3	Cross-disciplinary/Combined cardiothoracic surgery (esophagus+α)

H. Heart

4	H-1	Acyanotic congenital heart disease
5	H-2	Aortic arch anomaly/coarctation of aorta
6	H-3	Hypoplastic left heart syndrome: HLHS
7	H-4	Transposition of great arteries
8	H-5	Miscellaneous cyanotic diseases
9	H-6	Long-term issues/complications
10	H-7	Adult congenital heart disease
11	H-8	Congenital heart disease others
12	H-9	Valvular disease-aortic
13	H-10	Valvular disease-mitral
14	H-11	Valvular disease-tricuspid
15	H-12	Valvular disease-pulmonary
16	H-13	Valvular disease-combined
17	H-14	Valvular disease-MICS/Robotics
18	H-15	Valvular disease-TAVI/MitraClip
19	H-16	Valvular disease-infective endocarditis
20	H-17	Valvular disease-others
21	H-18	Ischemic heart disease-CABG
22	H-19	Ischemic heart disease-minimally invasive CABG
23	H-20	Ischemic heart disease-complications of myocardial infarction
24	H-21	Ischemic heart disease-others
25	H-22	Aorta-type A dissection
26	H-23	Aorta-type B dissection
27	H-24	Aorta-complications of aortic dissection
28	H-25	Aorta-aortic root
29	H-26	Aorta-ascending/arch
30	H-27	Aorta-descending
31	H-28	Aorta-thoracoabdominal
32	H-29	Aorta-esophageal/bronchial fistula
33	H-30	Aorta-infected aneurysm/graft infection
34	H-31	Aorta-others
35	H-32	Combined surgery (valve, coronary, aorta, etc.)
36	H-33	Arrhythmia, pacemaker
37	H-34	Maze surgery
38	H-35	Closure/resection of LAA
39	H-36	Cardiac tumor
40	H-37	Cardiomyopathy/myocarditis
41	H-38	Heart/heart-lung transplantation
42	H-39	Myocardial protection and metabolism
43	H-40	Extracorporeal circulation
44	H-41	Assisted circulation/ventricular assisted system
45	H-42	Perioperative management and complications
46	H-43	Examination and diagnosis
47	H-44	Experiment
48	H-45	New surgical techniques
49	H-46	Development and innovation
50	H-47	Regenerative medicine and tissue engineering
51	H-48	Others

L. Lung

52	L-1	Lung cancer
53	L-2	Pulmonary metastasis
54	L-3	Pulmonary neuroendocrine tumor
55	L-4	Mediastinum (thymic disease)
56	L-5	Mediastinum (non-thymic disease)
57	L-6	Pleura, chest wall, and thorax
58	L-7	Trachea and bronchus
59	L-8	Pneumothorax and emphysematous/bullous lung disease
60	L-9	Inflammatory lung diseases
61	L-10	Benign lung tumor
62	L-11	Pediatric lung disease
63	L-12	Minimally invasive surgery (Video-assisted and Robot-assisted thoracic surgery)
64	L-13	Salvage surgery, relapse therapy, oligometastases
65	L-14	Lung transplantation and assisted circulation
66	L-15	New surgical techniques・device
67	L-16	Perioperative management and complications and high-risk patients
68	L-17	Examination and diagnosis
69	L-18	Gene and molecular biology
70	L-19	Regenerative medicine
71	L-20	Others（education・work share・team medicine・others）

E. Esophagus

72	E-1	Esophageal malignancies
73	E-2	Esophageal benign diseases
74	E-3	Barrett's esophagus and adenocarcinoma
75	E-4	Esophagectomy and lymphadenectomy
76	E-5	Esophageal reconstruction
77	E-6	Minimally invasive and robot-assisted surgery
78	E-7	Multidisciplinary treatment
79	E-8	Salvage surgery and conversion surgery
80	E-9	Treatment for recurrent esophageal cancer
81	E-10	Perioperative management and complications
82	E-11	Surgical training
83	E-12	Aortoesophageal fistula
84	E-13	Surgical anatomy
85	E-14	Genetics and molecular biology
86	E-15	Pathology and experimental research
87	E-16	Palliative treatment
88	E-17	Esophageal cancer in elderly
89	E-18	Multiple primary malignant tumors
90	E-19	Others

7) Presentation format

Information about presentation format and methodology requirements will be released in due course. These requirements are subject to change. Applicants are advised to check the website for the latest information.

Abstract Submission

Ciphertext-based（recommended）

Abstract Submission Confirm, Modify & Delete

Plaintext-based

Abstract Submission Confirm, Modify & Delete

Inquiries

Secretariat of the 78th Annual Scientific Meeting of the Japanese Association for Thoracic Surgery

c/o Congrès Inc.

E-mail: jats2025-abs@congre.co.jp